Omeros Corporation
NASDAQ:OMERBiotechnology
Healthcare
$14.55 +4.46%
+$0.43 today
- Market cap
- $1.08B
- Beta
- 2.53
- P/E (TTM)
- 8.4
- EPS (TTM)
- $1.20
52W Low $2.95High $17.65
Volume 2.53M
Average 1.55M
Income Statement
Follow revenue through to earnings.
Revenue
$0.00
FY 2025 · Annual
Operating Income
-$122.80M
FY 2025 · Annual
Net Income
-$3.35M
FY 2025 · Annual
Income Statement
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 1.39M | 0 | 0 | 0 | 0 |
| Gross Profit | (1.39M) | 0 | 0 | 0 | 0 |
| Gross Margin | — | — | — | — | — |
| Research & Development | 118.78M | 112.72M | 114.87M | 119.52M | 81.3M |
| Selling, General & Admin | 53.46M | 50.67M | 49.66M | 49.74M | 41.5M |
| Operating Expenses | 172.23M | 163.39M | 164.53M | 169.26M | 122.8M |
| Depreciation & Amortization | 1.39M | 952K | 920K | 950K | 964K |
| EBITDA | (170.49M) | (158.38M) | (143.16M) | (157M) | (1.83M) |
| EBITDA Margin | — | — | — | — | — |
| Operating Income | (173.62M) | (163.39M) | (164.53M) | (169.26M) | (122.8M) |
| Operating Margin | — | — | — | — | — |
| Interest Income | 17.93K | 4.06M | 16.34M | 11.3M | 5.06M |
| Interest Expense | 19.67M | 22.7M | 30.84M | 24.68M | 0 |
| Other Income / Expenses | (17.93M) | (18.64M) | (10.39M) | (13.37M) | 120M |
| Income Before Tax | (191.55M) | (182.03M) | (174.92M) | (182.63M) | (2.8M) |
| Pre-Tax Margin | — | — | — | — | — |
| Income Tax Expense | 0 | 0 | 0 | 0 | 2.01M |
| Net Income | (111.41M) | 47.42M | (117.81M) | (156.82M) | (3.35M) |
| Net Margin | — | — | — | — | — |
| EPS (Basic) | 3.12 | 0.46 | (1.88) | (2.70) | (0.05) |
| EPS (Diluted) | 3.12 | 0.46 | (1.88) | (2.70) | (0.05) |
| 62.34M | 62.74M | 62.74M | 58.17M | 63.51M | |
| 62.34M | 62.74M | 62.74M | 58.17M | 63.51M |
OMER Earnings Waterfall · TTM
NASDAQ:OMER · Revenue to Net Income
Key Ratios
EPS$1.30
Gross Margin22.9%
Net Margin141.7%
P/E Ratio0.7
P/S Ratio19.2
Analysis
$9.9M of revenue converted into $86.2M of net income for the selected period. Gross margin is 22.9% and net margin is 141.7%, showing how much revenue survives after costs and taxes. EPS is $1.30, tying the income statement back to per-share earnings.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 8-K | Current report | Oct 30, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 30, 2026 | |
| 4 | Statement of changes in beneficial ownership | Sep 24, 2026 | |
| 4 | Statement of changes in beneficial ownership | Sep 1, 2026 | |
| 4 | Statement of changes in beneficial ownership | Aug 28, 2026 |
How much revenue does OMER generate?
Omeros Corporation (OMER) reported $0.00 of revenue in fiscal 2025.
Is OMER profitable?
Omeros Corporation (OMER) reported -$3.35M of net income.
Continue the stock analysis
Jump to another research area for this company.